Revive Therapeutics Stock Market Value
| RVVTF Stock | USD 0.01 0 7.69% |
| Symbol | Revive |
Revive Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Revive Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Revive Therapeutics.
| 05/06/2025 |
| 08/04/2025 |
If you would invest 0.00 in Revive Therapeutics on May 6, 2025 and sell it all today you would earn a total of 0.00 from holding Revive Therapeutics or generate 0.0% return on investment in Revive Therapeutics over 90 days. Revive Therapeutics is related to or competes with Relief Therapeutics, and Compass Pathways. Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare diso... More
Revive Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Revive Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Revive Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 25.69 | |||
| Value At Risk | (11.76) | |||
| Potential Upside | 7.69 |
Revive Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Revive Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Revive Therapeutics' standard deviation. In reality, there are many statistical measures that can use Revive Therapeutics historical prices to predict the future Revive Therapeutics' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (1.38) | |||
| Treynor Ratio | (2.39) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Revive Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Revive Therapeutics Backtested Returns
Revive Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0499, which implies the firm had a -0.0499 % return per unit of risk over the last 3 months. Revive Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Revive Therapeutics' Coefficient Of Variation of (1,123), risk adjusted performance of (0.06), and Variance of 38.86 to confirm the risk estimate we provide. The company holds a Beta of 0.24, which implies not very significant fluctuations relative to the market. As returns on the market increase, Revive Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Revive Therapeutics is expected to be smaller as well. At this point, Revive Therapeutics has a negative expected return of -0.31%. Please make sure to check Revive Therapeutics' potential upside, rate of daily change, as well as the relationship between the Rate Of Daily Change and period momentum indicator , to decide if Revive Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.43 |
Modest reverse predictability
Revive Therapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between Revive Therapeutics time series from 6th of May 2025 to 20th of June 2025 and 20th of June 2025 to 4th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Revive Therapeutics price movement. The serial correlation of -0.43 indicates that just about 43.0% of current Revive Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.43 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Revive Therapeutics lagged returns against current returns
Autocorrelation, which is Revive Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Revive Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Revive Therapeutics returns to help us make a trade decision. For example, suppose you find that Revive Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Revive Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Revive Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Revive Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Revive Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Revive Therapeutics Lagged Returns
When evaluating Revive Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Revive Therapeutics pink sheet have on its future price. Revive Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Revive Therapeutics autocorrelation shows the relationship between Revive Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Revive Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in Revive Pink Sheet
Revive Therapeutics financial ratios help investors to determine whether Revive Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Revive with respect to the benefits of owning Revive Therapeutics security.